One year ago | Fierce Biotech
The 2016 U.S. election had a big, albeit short lived, effect on biopharma, with Hilary Clinton's drug pricing tweet sinking stocks and putting a chill on a hot IPO market.
Read more ...
2 years ago | Xconomy
Duo Security , a cybersecurity startup based in Ann Arbor, MI, announced today that it is opening a new office in Detroit to accommodate the company's rapidly growing business...
Read more ...
3 years ago | Duke University
A BRIEF HISTORY OF EVERYONE WHO EVER LIVED: The Human Story Retold Through Our Genes, By Adam Rutherford.
Review by Dr. Misha Angrist .
A recent and, even by its own lofty...
Read more ...
4 years ago | ScienceDirect | 2 articles
Publication date: Available online 14 December 2016
Author(s): Nathan Ward, Kathy Stiller, Hilary Rowe, Anne E Holland
Background There are few tools to quantify the impact of...
Read more ...
4 years ago
My friend Eileen and I are planning to “phone-watch” the first presidential debate together on Monday. Just by calling her number in Louisiana from my couch in the Bay Area...
Read more ...
4 years ago | 3 articles
Who will be the next president of the United States was the topic of Wednesday's keynote at the 2016 BIO International Convention in San Francisco. This year's unique panel of...
Read more ...
4 years ago | 4 articles
MENLO PARK, Calif., Feb. 25, 2016 /PRNewswire/ - BioPharmX Corporation (NYSE MKT: BPMX) today announced the formation of a Therapeutic Dermatology Advisory Board composed of...
Read more ...
4 years ago | 7 articles
Joanna Zhao's and Jenny Bryan's R graph catalog is meant to be a complement to the physical book, Creating More Effective Graphs , but it's a really nice gallery in its own...
Read more ...
Register you to post on BioTech Mag
Free Registration
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...
This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...
Bond Life Sciences Center principal investigators Bing Yang and Ron Mittler are pictured above. | photos by Erica Overfelt, Bond LSC. By Lauren Hines | Bond LSC Building onto... Read more ...
Sam Barber, left, a research scientist at Berkeley Lab's BELLA Center, and Jeroen van Tilborg, a staff scientist at the BELLA Center, hold the active plasma lens, right, and... Read more ...
In cell studies, Mayo researchers and collaborators have uncovered why tumor cells from glioblastoma are more aggressive in one part of the brain than in others. In an article... Read more ...
Abstract Background An impressive percentage of biomedical advances were achieved through animal research and cell culture investigations. For drug testing and disease... Read more ...
Written By: PSC Software Business Development and Marketing Teams PSC Software , a wholly owned subsidiary of PSC Biotech Corporation , is pleased to announce the integration... Read more ...
Written By: Akshaya Mohan, Regulatory Affairs Manager, PSC Biotech® Documentation is a “record” or “evidence” of an event that has happened. In the life-science industry “If it... Read more ...
Researchers used single-molecule imaging to compare the genome-editing tools CRISPR-Cas9 and TALEN. Their experiments revealed that TALEN is up to five times more efficient... Read more ...
Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable... Read more ...
Non-model microorganisms often possess complex phenotypes that could be important for the future of biofuel and chemical production. They have received significant interest the... Read more ...
SAN DIEGO--Design Therapeutics Secures $125 Million in Series B Financing to Advance Pipeline of Genomic Medicines for Nucleotide Repeat Expansion Disorders... Read more ...